Corrigendum to: Mortality in Parkinson's Disease: A 38-Year Follow-up Study (Mov Disord (2015), 30, 266-269, 10.1002/mds.26060);Mortality in Parkinson's disease: A 38-year follow-up study

Movement Disorders

Volumn 30, Issue 2, 2015, Pages 266-269

  Pinter, Bernadette ^a   Diem Zangerl, Anja ^a   Wenning, Gregor Karl ^a   Scherfler, Christoph ^a   Oberaigner, Willi ^b   Seppi, Klaus ^a   Poewe, Werner ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Tyrolean State Hospitals Ltd Institute for Clinical Epidemiology   (Australia)

Author keywords

Cause specific mortality; Late stage; Mortality; Parkinson's disease; SMR

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE SPECIFIC SURVIVAL; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; ONSET AGE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARKINSON DISEASE; PNEUMONIA; PRIORITY JOURNAL; SEX DIFFERENCE; STANDARDIZED MORTALITY RATIO; SYMPTOM; AGED; CAUSE OF DEATH; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; TREMOR; VERY ELDERLY;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PROPORTIONAL HAZARDS MODELS; SEX FACTORS; TREMOR;

EID: 84922266292     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26914     Document Type: Erratum

References (35)

1. Diem-Zangerl A, Seppi K, Wenning GK, Trinka E, Ransmayr G, Oberaigner W, Poewe W. Mortality in Parkinson's disease: a 20-year follow-up study. Mov Disord 2009;24:819-825.
2. Herlofson K, Lie SA, Arsland D, Larsen JP. Mortality and Parkinson disease: a community based study. Neurology 2004;62:937-942.
3. Forsaa EB, Larsen JP, Wentzel-Larsen T, Alves G. What predicts mortality in Parkinson disease?: a prospective population-based long-term study. Neurology 2010;75:1270-1276.
4. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008;23:837-844.
5. Gorell JM, Johnson CC, Rybicki BA. Parkinson's disease and its comorbid disorders: an analysis of Michigan mortality data, 1970 to 1990. Neurology 1994;44:1865-1868.
6. Ben-Shlomo Y, Marmot MG. Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? J Neurol Neurosurg Psychiatry 1995;58:293-299.
7. Duarte J GOL, Mendoza A, Clavería LE. The natural history of Parkinson's disease in the province of Segovia: mortality in a longitudinal study (20-year follow-up). Acta Neurol Scand 2013;127:295-300.
8. Oberaigner W, Stühlinger W. Record linkage in the Cancer Registry of Tyrol, Austria. Methods Inf Med 2005;44:626-630.
9. Oberaigner W. Department of Clinical Epidemiology of the Tyrolean State Hospital, Wilhelm-Greil-Straße 25, A-6020 Innsbruck. www.iet.at.
10. Statistics Austria, Departement of Population, Guglgasse 13, A-1110 Vienna. www.statistik.at.
11. World Health Organisation. Manual of the international classification of disease injuries and causes of death. 10th revision. Geneva, Switzerland: WHO; 1990.
12. Chen H, Zhang SM, Schwarzschild MA, Hernán MA, Ascherio A. Survival of Parkinson's disease patients in a large prospective cohort of male health professionals. Mov Disord 2006;21:1002-1007.
13. Mortality in DATATOP: a multicenter trial in early Parkinson's disease. Parkinson Study Group. Ann Neurol 1998;43:318-325.
14. Marras C, McDermott MP, Rochon PA, et al. Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort. Neurology 2005;64:87-93.
15. Hely MA, Morris JG, Traficante R, Reid WG, O'Sullivan DJ, Williamson PM. The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry 1999;67:300-307.
16. Hely MA, Morris JG, Reid WG, Trafficante R: Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 2005;20:190-199.
17. Beyer MK, Herlofson K, Arsland D, Larsen JP. Causes of death in a community-based study of Parkinson's disease. Acta Neurol Scand 2001;103:7-11.
18. Pennington S, Snell K, Lee M, Walker R. The cause of death in idiopathic Parkinson's disease. Parkinsonism Relat Disord 2010;16:434-437.
19. Fall PA, Saleh A, Fredrickson M, Olsson JE, Granérus AK. Survival time, mortality, and cause of death in elderly patients with Parkinson's disease: a 9-year follow-up. Mov Disord 2003;18:1312-1316.
20. D'Amelio M, Ragonese P, Morgante L, Reggio A, Callari G, Salemi G, Savettieri G. Long-term survival of Parkinson's disease: a population-based study. J Neurol 2006;253:33-37.
21. Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G. Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study. Neurology 2008;70:1423-1430.
22. Wermuth L, Stenager EN, Stenager E, Boldsen J. Mortality in patients with Parkinson's disease. Acta Neurol Scand 1995;92:55-58.
23. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
24. Ferreira JJ, Neutel D, Mestre T, Coelho M, Rosa MM, Rascol O, Sampaio C. Skin cancer and Parkinson's disease. Mov Disord 2010;25:139-148.
25. Rugbjerg K, Friis S, Lassen CF, Ritz B, Olsen JH. Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease. Int J Cancer 2012;131:1904-1911.
26. Liu R, Gao X, Lu Y, Chen H. Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology 2011;76:2002-2009.
27. Wirdefeldt K, Weibull CE, Chen H, Kamel F, Lundholm C, Fang F, Ye W. Parkinson's disease and cancer: a register-based family study. Am J Epidemiol 2014;179:85-94.
28. Ishihara LS, Cheesbrough A, Brayne C, Schrag A. Estimated life expectancy of Parkinson's patients compared with the UK population. J Neurol Neurosurg Psychiatry 2007;78:1304-1309.
29. Schrag A, Ben-Shlomo Y, Brown R, Marsden CD, Quinn N. Young-onset Parkinson's disease revisited: clinical features, natural history, and mortality. Mov Disord 1998;13:885-894.
30. Berger K, Breteler MM, Helmer C, et al. Prognosis with Parkinson's disease in Europe: A collaborative study of population-based cohorts: neurologic diseases in the elderly research group. Neurology 2000;54(11 Suppl 5):S24-S27.
31. Chió A, Magnani C, Tolardo G, Schiffer D. Parkinson's disease mortality in Italy, 1951 through 1987: analysis of an increasing trend. Arch Neurol 1993;50:149-153.
32. Kurtzke JF, Murphy FM: The changing patterns of death rates in parkinsonism. Neurology 1990;40:42-49.
33. Poewe WH, Wenning GK. The natural history of Parkinson's disease. Ann Neurol 1998;44(3 Suppl 1):S1-S9.
34. Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology 1985;35:522-526.
35. Marttila RJ, Rinne UK, Siirtola T, Sonninen V. Mortality of patients with Parkinson's disease treated with levodopa. J Neurol 1977;216:147-153.